The tumor is reported to be latency pattern III by expressing EBNA1, EBNA2, LMP1, and LMP2A [215] or a variant of latency type III through the expression of EBNA2 or EBNA3 but no LMP1. This evidence concerns the gene PDLIM7 and neoplasm.